News

"PM Modi has taken steps to free the country from sickle cell and thalassemia. All efforts will be made to create quality treatment facilities in government colleges here to free patients from this ...
Sickle cell disease (SCD) warriors in Western Kenya have launched a campaign to end stigma and raise awareness about the ...
Shares of CRISPR Therapeutics have lost momentum in recent years. Despite making significant clinical progress, CRISPR ...
G ene therapy has always held enormous promise to correct genetic diseases, but turning that potential into treatments has ...
NEW DELHI: In pursuance of its commitment to Prime Minister Narendra Modi’s Neighbourhood First Policy, India on Friday sent medical assistance worth $2 million to Nepal for patients suffering from ...
Family overjoyed correction to DNA defect that causes metabolic disorder has given KJ Muldoon a new lease of life ...
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...
In a historic medical breakthrough, a child diagnosed with a rare genetic disorder has been successfully treated with a customized CRISPR gene editing therapy by a team at Children's Hospital of ...
In a historic medical breakthrough, a child diagnosed with a rare genetic disorder has been successfully treated with a ...
The centre is set to provide a patient-centric approach to treatment, backed by a multidisciplinary team of specialists.
About PYRUKYND® (mitapivat) U.S. INDICATION PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.
CAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company, today announced that new data from a study in non-human primates (NHPs) has ...